Related Experiment Videos
The effects of estramustine on metaphase and anaphase in DU 145 prostatic carcinoma cells
V R Sheridan1, L A Speicher, K D Tew
1Department of Pharmacology, Fox Chase Cancer Center, Philadelphia, PA 19111.
Abstract:
The chemotherapeutic drug, estramustine, has been shown to cause the disassembly of microtubules via binding to microtubule-associated proteins. In this report, estramustine is shown to be a potent inhibitor of mitotic progression in the human prostatic carcinoma cell line, DU 145. Examination of individual living cells via video-enhanced differential interference contrast (DIC) optics shows that the drug delays the onset of anaphase, reduces anaphase spindle-pole elongation (anaphase B), and delays cytokinesis. In addition, immunofluorescent studies demonstrate that estramustine causes a rapid disorganization of the mitotic apparatus at significantly lower concentrations than those reported previously. Electron microscopic studies show that microtubule bundles are present in drug-treated mitotic cells in association with kinetochores and centrioles.
Insights
Estramustine, a chemotherapy drug, effectively halts cancer cell division by disrupting microtubules. This study reveals its potent inhibition of mitotic progression in prostate cancer cells.
Area of Science:
- Oncology
- Cell Biology
- Biochemistry
Background:
- Estramustine is a chemotherapeutic agent known to affect microtubules.
- Microtubule-associated proteins (MAPs) are implicated in estramustine's mechanism of action.
- Prostate carcinoma cell lines provide a model for studying anti-cancer drug efficacy.
Purpose of the Study:
- To investigate the effects of estramustine on mitotic progression in the DU 145 human prostate carcinoma cell line.
- To characterize the morphological and structural changes induced by estramustine during mitosis.
- To determine the concentration-dependent effects of estramustine on the mitotic apparatus.
Main Methods:
- Video-enhanced differential interference contrast (DIC) microscopy for live-cell imaging.
- Immunofluorescence microscopy to visualize the mitotic spindle.
- Electron microscopy for ultrastructural analysis of treated cells.
Main Results:
- Estramustine significantly inhibits mitotic progression in DU 145 cells, delaying anaphase onset and cytokinesis.
- The drug causes rapid disorganization of the mitotic apparatus at lower concentrations than previously reported.
- Microtubule bundles were observed associated with kinetochores and centrioles in estramustine-treated cells.
- Reduced anaphase spindle-pole elongation (anaphase B) was observed.
Conclusions:
- Estramustine is a potent inhibitor of mitosis in prostate cancer cells.
- The drug's mechanism involves disruption of microtubule organization and function.
- Estramustine's effects on the mitotic apparatus warrant further investigation for therapeutic applications.